News | June 11, 2025
Lubrizol's polymer excipient Apisolex featured in Phase I candidate
The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold
The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold
The acquisition sets up the foundation for a central hub of GMP value-added services and greater access to new customers in the rapidly growing Biopharma market
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
Oxcarbazepine ER Tablets (RLD Oxtellar XR) had estimated annual sales of US$ 206 million in the US (IQVIA MAT April 2025)
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
If approved, linerixibat could address high unmet medical need of patients living with cholestatic pruritus (relentless itch) and related sleep interference
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Subscribe To Our Newsletter & Stay Updated
